Research Topics
Genomes and Genes
| S M BoekholdtSummaryAffiliation: Academic Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysisS Matthijs Boekholdt
Department of Cardiology, Room F3 241, Academic Medical Center, PO Box 22660, 1100 DD, Amsterdam, The Netherlands
Hum Genet 113:417-25. 2003..These data suggest that the relationship between apoB levels, hypercholesterolemia and IHD risk cannot have a simple molecular basis in the apoB gene...
Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Br J Nutr 96:516-22. 2006..These data suggest that the risk reduction associated with higher ascorbic acid plasma concentrations, a marker of fruit and vegetable intake, is independent of classical risk factors and also independent of CRP concentration...
Physical activity, C-reactive protein levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands
Eur J Cardiovasc Prev Rehabil 13:970-6. 2006..Whether this relationship is in part mediated by lower levels of systemic inflammation, as indicated by C-reactive protein concentrations, is unknown...
Arterial thrombosis and the role of thrombophiliaS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Semin Thromb Hemost 33:588-96. 2007..We conclude that thrombophilia screening in unselected patient populations with myocardial infarction or ischemic stroke is not justified...
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levelsS M Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Clin Genet 69:263-70. 2006..Multiple environmental and genetic influences on HDL-C plasma levels still have to be elucidated...
[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]S M Boekholdt
Academisch Medisch Centrum Universiteit van Amsterdam, afd Cardiologie
Ned Tijdschr Geneeskd 151:2615-9. 2007..Whether the beneficial effects of rimonabant on weight reduction and cardiovascular risk factors translate into a reduction in cardiovascular morbidity and mortality remains to be established in large phase III trials...
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarctionS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 22:e24-7. 2002..It was our objective to verify this hypothesis in an independent cohort...
Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Clin Endocrinol (Oxf) 72:404-10. 2010..Thyroid status affects several aspects of cardiovascular risk profile, including lipid levels and blood pressure. Whether thyroid status affects the risk of coronary heart disease (CHD) and all-cause mortality remains controversial...
Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population StudyJ S Rana
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Intern Med 262:678-89. 2007..There is paucity of data on the differential leucocyte count and its relationship with the risk of CHD and CVD...
Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population studyA G Holleboom
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Lipid Res 51:416-21. 2010..45, CI: 0.94-2.22, P for linearity = 0.036). In contrast to our studies in carriers of LCAT mutations, the current data show that low LCAT plasma levels are not associated with increased atherosclerosis in the general population...
Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemiaEmily S van Aalst-Cohen
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Eur J Hum Genet 13:1137-42. 2005....
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 24:1503-8. 2004..To study the role of IL-8 in predicting future coronary artery disease (CAD) in apparently healthy men and women...
Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyT T Keller
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Thromb Haemost 4:2391-6. 2006..High levels of circulating TF are found in patients with acute atherothrombotic events. Whether high serum TF levels predict risk of future CAD independent of known risk factors remains unknown...
Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population StudyStefan F C Vaessen
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Lipid Res 47:2064-70. 2006..The positive correlation of apoA-V levels with TG levels, negative correlation with LPL levels, and lack of association with CAD risk highlight the need for further human studies to clarify the role of apoA-V...
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population studyS M Boekholdt
Department of Cardiology and Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Thromb Haemost 4:2204-9. 2006..The factor (F) XIII Val34Leu variant has been implicated in coronary artery disease (CAD). In vitro evidence suggests an interaction between this variant and fibrinogen concentrations in determining thrombus structure...
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt
Department of Cardiology, Academic Medical Center, Academic Medical Center, Amsterdam, The Netherlands
Circulation 111:278-87. 2005..In addition, an interaction has been implicated between this genetic variant and pravastatin treatment, but this has not been confirmed...
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studiesWim A van der Steeg
Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
J Am Coll Cardiol 51:634-42. 2008....
Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population StudySabine Pinedo
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Lipid Res 48:139-44. 2007..29) and the adjusted OR was 0.97 (95% CI = 0.68-1.39). In this large prospective study, higher levels of plant sterols, at least in the physiological range, do not appear to be adversely related to CAD in apparently healthy individuals...
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003S Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Atherosclerosis 187:415-22. 2006..Measurement of C-reactive protein (CRP) levels has been proposed as a useful marker to improve the prediction of future coronary artery disease (CAD) risk, but this notion has been challenged recently...
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Am J Med 117:390-7. 2004..However, the data support a regulatory role for macrophage migration inhibitory factor in the process of atherosclerosis...
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyKarim El Harchaoui
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
J Am Coll Cardiol 49:547-53. 2007..We assessed relations of low-density lipoprotein (LDL) particle number (LDL-P) and LDL particle size as measured by nuclear magnetic resonance spectroscopy with LDL cholesterol (LDL-C) and the risk of future coronary artery disease (CAD)...
Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-NorfolkWim A van der Steeg
Academic Medical Center, Amsterdam, The Netherlands
Ann Intern Med 146:640-8. 2007..It is not known whether this ratio is better than traditional lipid values for risk assessment and prediction and whether it adds predictive value to the Framingham risk score...
Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population studyJaap Rip
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 26:637-42. 2006..CONCLUSIONS: Reduced levels of serum LPL are associated with an increased risk for future CAD. The data suggest that high LPL concentrations may be atheroprotective through decreasing TG levels and increasing HDL-C levels...
Role of CETP inhibitors in the treatment of dyslipidemiaW A van der Steeg
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands
Curr Opin Lipidol 15:631-6. 2004....
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population StudyMarijn C Meuwese
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Am Coll Cardiol 50:159-65. 2007..We evaluated whether serum myeloperoxidase (MPO) levels are associated with the risk of future development of coronary artery disease (CAD) in apparently healthy individuals...
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibilityMenno Vergeer
Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
Circulation 122:470-7. 2010....
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population StudyRakesh S Birjmohun
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
PLoS ONE 4:e6809. 2009..In order to evaluate the atheroprotective potential of PON1, we assessed the relationships among PON1-genotype, PON1-activity and risk of future coronary artery disease (CAD), in a large prospective case-control study...
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteersNick R Bijsterveld
Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
Circulation 106:2550-4. 2002..The aim of this study was to investigate whether recombinant factor VIIa (rFVIIa) could neutralize the anticoagulant effects of subcutaneously administered fondaparinux...
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and diseaseS Matthijs Boekholdt
Academic Medical Center, Department of Cardiology, Room F3 241, 1100 DD Amsterdam, The Netherlands
J Lipid Res 44:1080-93. 2003..05 mmol/l higher HDL levels in 405VV homozygotes than in 405II homozygotes (95% CI = 0.03-0.07, P < 0.0001). The implications of these studies for cardiovascular disease will be addressed...
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatmentJohn J P Kastelein
Academic Medical Center, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands
Circulation 117:3002-9. 2008....
Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular eventsS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Am Heart J 147:181-6. 2004..We investigated whether the effect of this genetic variant of the platelet fibrinogen receptor on the risk of cardiovascular events is affected by fibrinogen plasma levels...
Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseDiederik F van Wijk
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 30:1460-6. 2010..In humans, evidence about the association between levels of monocyte chemoattractant protein-1 (MCP-1), its coding gene chemokine (C-C motif) ligand 2 (CCL2), and risk of coronary artery disease (CAD) is contradictory...
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 25:839-46. 2005..The magnitude of the association was similar to that observed between CRP and CAD risk, and both associations were independent...
Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CADOlga W Souverein
Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
Eur J Hum Genet 13:445-51. 2005..Nevertheless, only a small part of variation in TG levels could be explained by the polymorphisms...
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVTMenno Vergeer
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Atherosclerosis 211:558-64. 2010..We determined whether five tagging single nucleotide polymorphisms (SNP) in LIPG were associated with lipid parameters, the risk of CAD and the risk of DVT...
Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene polymorphismsSaskia Z H Rittersma
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Clin Chem 51:516-21. 2005..We evaluated the association between polymorphisms in the Toll-like receptor 4 (TLR4) gene and cytokine response after lipopolysaccharide (LPS) challenge and the development of ISR...
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and womenTymen T Keller
Academic Medical Center of Amsterdam, Department of Vascular Medicine Room F4 121, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 26:2345-50. 2006..To determine the association between serum levels of mannose-binding lectin (MBL) and the risk of future coronary artery disease (CAD) in apparently healthy men and women...
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population studyS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Circulation 110:1418-23. 2004..87 (95% CI 1.06 to 3.30, P=0.02). CONCLUSIONS: Elevated CETP levels are associated with an increasing risk of future CAD in apparently healthy individuals, but only in those with high triglyceride levels...
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic reviewS M Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, Netherlands
Circulation 104:3063-8. 2001..In the absence of clinical implications, our results indicate that screening of patients with myocardial infarction for these genetic variations is not warranted...
CETP gene variation: relation to lipid parameters and cardiovascular riskS Matthijs Boekholdt
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
Curr Opin Lipidol 15:393-8. 2004..No evidence exists for a pharmacogenetic interaction between the CETP TaqIB variant and pravastatin efficacy...
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle sizeBenoit J Arsenault
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Clin Chem 56:789-98. 2010..However, whether or not GGE- or NMR-measured LDL or HDL particle size predicts coronary heart disease (CHD) risk to a similar extent is currently unknown...
Prolactin levels and the risk of future coronary artery disease in apparently healthy men and womenAnne Q Reuwer
Departments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Circ Cardiovasc Genet 2:389-95. 2009..Because inflammation is considered of crucial importance in the development of atherosclerosis, we aimed to evaluate whether prolactin levels are associated with the occurrence of coronary artery disease (CAD)...
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui
Academic Medical Center, Amsterdam, The Netherlands
Ann Intern Med 150:84-93. 2009..Because HDL particles are heterogeneous in size and composition, they may be differentially associated with other cardiovascular risk factors and with cardiovascular risk...
Inherited disorders of HDL metabolism and atherosclerosisG Kees Hovingh
Department of Vascular Medicine, Academic Medical Center, AZ Amsterdam, The Netherlands
Curr Opin Lipidol 16:139-45. 2005..This insight is of interest, since it can assist in the prioritizing of antiatherogenic therapy by increasing HDL cholesterol levels...
Apolipoprotein A-II is inversely associated with risk of future coronary artery diseaseRakesh S Birjmohun
Academic Medical Center, Department of Vascular Medicine, 1100 DD, Amsterdam, The Netherlands
Circulation 116:2029-35. 2007..To study this suggestion more closely, we evaluated how serum levels of apoA-II and apoA-I relate to the risk of future coronary artery disease (CAD) in a large, prospective study...
Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosisSaskia Z H Rittersma
Am J Med 116:499-500. 2004
Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studiesNadeem Sarwar
Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, UK
Circulation 115:450-8. 2007..In the present study, we report 2 separate nested case-control comparisons in 2 different prospective, population-based cohorts, plus an updated meta-analysis of 27 additional prospective studies in general Western populations...
Gene polymorphisms and the risk of myocardial infarction--an emerging relationRon J G Peters
N Engl J Med 347:1963-5. 2002
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population studyBenoit J Arsenault
Department of Cardiology, Quebec Heart Institute, Hôpital Laval Research Centre, Pavilion Marguerite D Youville, 4th Floor, 2725, Chemin Sainte Foy, Quebec, QC, Canada G1V 4G5
Eur Heart J 28:2770-7. 2007..To evaluate the association of low-density lipoprotein cholesterol (LDL-C) levels in small and large LDL particles with risk of incident coronary heart disease (CHD)...
Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective studyDexter Canoy
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Circulation 116:2933-43. 2007..Body fat distribution has been cross-sectionally associated with atherosclerotic disease risk factors, but the prospective relation with coronary heart disease remains uncertain...
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?Rebecca K Simmons
MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, England
Arch Intern Med 168:1209-16. 2008..There is a continuous relationship between glycated hemoglobin (HbA(1c)) and coronary heart disease (CHD) risk, even below diagnostic thresholds for diabetes mellitus...
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular eventsS Matthijs Boekholdt
Leiden University Medical Center, Department of Cardiology C5 P, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, The Netherlands
Circulation 107:2416-21. 2003....
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk studyZiad Mallat
INSERM U689, Centre de Recherché Cardiovasculaire Lariboisière, Paris, France
Arterioscler Thromb Vasc Biol 27:1177-83. 2007..To assess the association between secretory phospholipase A2 (sPLA2) activity, which encompasses several types of sPLA2, and cardiovascular disease (CAD) in healthy individuals...
Inhibition of lipoprotein-associated phospholipase activity by darapladib: shifting gears in cardiovascular drug development: are antiinflammatory drugs the next frontier?S Matthijs Boekholdt
Circulation 118:1120-2. 2008
Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesisAnke H E M Klerkx
Department of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Arterioscler Thromb Vasc Biol 26:706-15. 2006....
